EcoDrugPlus

Glutathione S-Transferase Pi 1

Ensembl ID : ENSLACG00000014785
Gene Symbol: GSTP1
2 Cross references
172 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSLACG00000006537
Gene Symbol: GSK3A
4 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSLACG00000011303
Gene Symbol: GSK3B
4 Cross references
241 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSLACG00000002185
Gene Symbol: GNRHR
4 Cross references
96 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSLACG00000013879
Gene Symbol: GHSR
4 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSLACG00000006322
Gene Symbol: GUCY1A1
2 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSLACG00000012886
Gene Symbol: GUCY1A2
2 Cross references
202 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSLACG00000000733
Gene Symbol: HSP90AA1
4 Cross references
55 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSLACG00000010351
Gene Symbol: HSP90AB1
4 Cross references
339 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSLACG00000006701
Gene Symbol: HMGB1
4 Cross references
582 Possible Orthologues:

Histamine H1 Receptor-Like

Ensembl ID : ENSLACG00000000768
Gene Symbol: LOC102349900
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSLACG00000009715
Gene Symbol: HRH2
4 Cross references
249 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).